Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|February 24, 2012
Gateway 2012: I Holland Limited
Advertisement
Your online Gateway to I Holland Limited in 2012
Meadow Lane, Long Eaton,
Nottingham, NG10 2GD, England
Telephone:+44 (0) 115 972 6153
Fax: +44 (0) 115 973 1789
I Holland Americas
1684 Target Court, Suite 3
Fort Myers, FL 33905
web:
Telephone: 1-800-420-2991
Email: [email protected]
About I Holland Limited
More than six decades of research, development and investment has established I Holland as the leading supplier of punches and dies to producers of tablets in a variety of sectors.
Our Commitment to understanding the science behind tabletting has led to the development of innovative materials, bespoke tablet/tool design and established quality assurance technology, all supported by unrivalled customer service.
I Holland is now the sole distributor of OTEC DF (Drag Finishing) machines and consumables in North America.
The automated polisher is just one part of our PharmaCare™ 7-Step Process, developed as a professional maintenance and storage program for punches & dies, enabling you to get the most out of your investment and increase your productivity.
See demonstrations of our PharmaCare™ equipment at Interphex booth#3532 or our newly opened Technical Support Center in Fort Myers, Florida.
I Holland Multi Tip Tooling
Research Document ‘Atomic Force Microscopy Anti-Sticking Research’
I Holland PharmaCareTM 7-Step Process
For more information:
Advertisement
Related to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
4
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
5